Shiga Progression of Diabetes, Nephropathy and Retinopathy
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the oral anti-diabetic drug, Thiazolidine
(TZD) is effective in suppression of onset or progressin of diabetic nephropathy in Japanese
type 2 diabetic patients.
Phase:
N/A
Details
Lead Sponsor:
Shiga University
Collaborators:
Ako City Hospital Horide Clinic Hyogo prefectural Amagasaki Hospital Kanazawa Medical University Kawabata Clinic Kohka Public Hospital Nagahama City Hospital Nagahama Red Cross Hospital NTT West Osaka Hospital Omihachiman COmmunity Medical Center Osaka University Sawada Clinic Second Okamoto General Hospital Seta Clinic Shiga Clinic Social Insurance Shiga Hospital Tomita Clinic Toyosato Hospital Yasu Hospital